Editors Note: Our colleague and Casey Research analyst Nick Giambruno just made a bold stock market prediction for the coming year that could generate a big windfall for early investors. We think you'll find it interesting... Dear Reader, I don't often make big predictions. But today I'm going out on a limb... Because this tiny $5 biotech stock has all the makings of a massive winner. They are breezing through the FDA approval process with a "holy serum" treatment that could be worth a total of $8.1 billion. The anticipated FDA announcement may come as early as 9:31 AM tomorrow... And it could send this tiny stock on a 4,100% run. Considering what's at stake here... I wouldn't be surprised if this is the biggest biotech winner of 2021. Go here to get the full story — before 9:31 am tomorrow. Regards, Nick Giambruno Chief Analyst, Casey Research P.S. One more thing... this $5 company isn't a one-trick pony. They are angling for another $6 billion market with one more "holy serum" treatment in the pipeline. And it could be worth a fortune to early investors. More details here. |
没有评论:
发表评论